FIRSTLUNG (L301): Cluster Randomized Trial Evaluating the Clinical Utility of DELFI's Blood-Based Lung Cancer Screening Test

dc.contributor.author	Cotton, L
dc.contributor.author	Cisar, C
dc.contributor.author	Bach, P
dc.contributor.author	Sheridan, C
dc.contributor.author	Trivedi, N
dc.contributor.author	Davis, J
dc.date.accessioned	2026-07-01T15:32:05Z
dc.date.available	2026-07-01T15:32:05Z
dc.date.issued	2024-10
dc.identifier.issn	1556-0864
dc.identifier.issn	1556-1380
dc.identifier.uri	https://hdl.handle.net/10161/34919
dc.relation.ispartof	JOURNAL OF THORACIC ONCOLOGY
dc.rights.uri	https://creativecommons.org/licenses/by-nc/4.0
dc.subject	blood-based test
dc.subject	lung cancer screening
dc.subject	low-dose computed tomography (LDCT)
dc.title	FIRSTLUNG (L301): Cluster Randomized Trial Evaluating the Clinical Utility of DELFI's Blood-Based Lung Cancer Screening Test
dc.type	Conference
duke.contributor.orcid	Davis, J\|0000-0002-7196-5649
pubs.begin-page	S214
pubs.end-page	S214
pubs.issue	10
pubs.organisational-group	Duke
pubs.organisational-group	School of Medicine
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Institutes and Centers
pubs.organisational-group	Medicine
pubs.organisational-group	Medicine, General Internal Medicine
pubs.organisational-group	Duke Cancer Institute
pubs.publication-status	Published
pubs.volume	19

Files

Now showing 1 - 1 of 1